Search

everythinglearnresearchcommunity

for

Search:↓

Black phosphorus nanosheets help heal large wounds by reducing inflammation and promoting tissue regeneration.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

JAK inhibitors might help treat alopecia areata.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Ruxolitinib can help regrow hair in severe alopecia areata.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Hair loss requires customized treatments based on its various causes and types.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Key genes and pathways, including Wnt, NF-Kappa, and JAK-STAT, are crucial for starting Pashmina fiber growth in goats.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.